Delivery Order SPE2DX15D6038-SPE2DX24F2AR5
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for 4563322636 VALSARTAN-HCTZ 160-12.5 MG TAB 90S and has a potential value of $3,863.08. The delivery order was awarded on January 12, 2024 with a completion date of January 16, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Amerisourcebergen Corporation. The contract is for the delivery of Valsartan-HCTZ 160-25 mg tablets in 90-count bottles, with a potential value of $4,891.58 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Valsartan-HCTZ 160-25 mg tablets in quantities of 90 units, with a contract ceiling value of $11,676.65. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $6,816.51 order is for the supply of 90 tablets of the pharmaceutical product Valsartan-HCTZ 320-25 mg. The delivery order was issued under Amerisourcebergen's existing indefinite delivery contract with DLA Troop Support Medical to provide pharmaceutical products and medical supplies in support of military...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $3,241.18 firm fixed price contract is for the supply of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract has an ultimate completion date of April 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,542.97 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply). This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. As a child delivery order under a...
- This delivery order, awarded August 27, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 90-count tablets of Valsartan-HCTZ 160-25 mg with a ceiling value of $3,617.52. The award is a firm fixed price, non-competitive set-aside delivery order executed under AmerisourceBergen's $999.99 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026. This parent contract serves as a comprehensive global...
- This delivery order, awarded July 21, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 90 tablets of Valsartan-HCTZ 160-12.5 mg with a ceiling value of $8,953.53. The contract is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 90 tablets of the prescription medication Valsartan-HCTZ 160-12.5 mg, with a potential value of $8,219.58 and a completion date of February 21, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order. No set-aside designation...
- SPE2DX15D6038Indefinite Delivery Contract
- SPE2DX15D6038-SPE2DX24F2AR5Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a for-profit pharmaceutical distribution company, to provide 90 tablets of the prescription medication Valsartan-HCTZ 160-12.5 mg. The $2,292.30 delivery order has a completion date of February 2, 2024. Amerisourcebergen Drug Corporation, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is issued under a larger indefinite delivery contract (IDC) that Amerisourcebergen Drug Corporation holds with DLA, valued at up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 2/1/24 |